Value-Driven Spine Care
David B. Nash, MD, MBA 1 I can vividly recall the day-now almost a decade agothat I injured my back while riding a Jet Ski with my son off the coast of Cape Cod. The persistent sciatic pain that followed began to interfere with my work as well as my favorite stress-reducing activity-tennis. When my pain continued to worsen over time, I was urged to have spinal fusion surgery in 2002. As a beneficiary of this technology, a practicing internist, and an expert in health policy, I have a special interest in the focus of this supplement, Value-Driven Spine Care.
Internists and family physicians are acutely aware of the toll low back pain (LBP) takes on more than 80% of Americans. 1 The National Center for Health Statistics (2007) reports that each year 14.3% of new patient visits to primary care physicians are for LBP. It should come as no surprise that the annual costs associated with LBP in the United States exceed $100 billion annually. 2 Although a majority of patients with LBP can be managed nonoperatively, spine surgery is a critical option for patients with conditions such as disabling herniated nucleus pulposus, lumbar spinal stenosis, or spondylolisthesis with stenosis. The growth in lumbar spine surgery rates over the past 15 years 2,3 -more than 650 000 surgical procedures annually in the United States-has raised legitimate concerns as costs soar beyond $20 billion. 3, 4 Stakeholders are understandably skeptical about spine surgery: payers question the value, the industry faces greater challenges in bringing new products to market, hospitals question the cost, and patients question the effectiveness of "back surgery."
In fact, the economic value of spinal surgeries is not well understood. Some studies have concluded that surgery is more effective than nonoperative therapy for stenosis. For example, the Spine Patient Outcomes Research Trial analysis suggested that surgical treatment of spinal stenosis with laminectomy provides reasonable value, even over a limited 2-year time frame. More costly surgeries (eg, for stenosis associated with degenerative spondylolisthesis) cannot be characterized as costeffective until a continued health benefit can be shown without ongoing costs. 5 A definitive, comprehensive assessment of the costeffectiveness of spinal surgery will require long-term outcomes data. However, the clinical, financial, and patientcentered aspects of these procedures can, and should, be addressed. To that end, a Spine Surgeon Leadership Council meeting was convened (Dallas, Texas, on January 17, 2009) to discuss the scientific and clinical issues regarding spine care and spinal surgery, define gaps in the evidence, address the value of spine care from multiple stakeholder perspectives, identify appropriate metrics and methods for transparent outcomes reporting, and develop consensus on the need for an evidence-based approach.
This supplement, a key derivative of the meeting, contains 3 articles that elucidate various aspects of value with respect to spine care. I hope that readers will find them enlightening and that they will stimulate discussion and further study on this issue that touches so many of our lives. As always, I welcome your questions and comments at: david.nash@jefferson.edu.
